Share on LinkedInShare on LinkedIn

ARTICLE · 03 JUNE 2024

CDA–AMC (Formerly CADTH) Announces Several Pilot Projects, Including Target Zero Initiative

CADTH is now known as Canada's Drug Agency (CDA-AMC or CDA). Its mandate extends beyond CADTH's mandate to include...

CanadaFood, Drugs, Healthcare, Life Sciences

CADTH is now known as Canada's Drug Agency (CDA-AMC or CDA). Its mandate extends beyond CADTH's mandate to include:

  • improving the appropriate prescribing and use of medications;
  • increasing pan-Canadian data collection and expanding access to drug and treatment data, including real-world evidence data; and
  • reducing drug system duplication and lack of coordination.

CDA has begun several major initiatives including the below:

  1. The Target Zero initiative aims to achieve zero days between Health Canada's regulatory approval of a drug and CDA's reimbursement recommendation to participating drug plans, to increase patient access. CDA accepts submissions 180 days before Health Canada's anticipated regulatory decision, which enables a parallel review process.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The preceding is intended as a timely update on Canadian intellectual property and technology law. The content is informational only and does not constitute legal or professional advice. To obtain such advice, please communicate with our offices directly.

See more popular content from